AAAAAA
Results: 26-50/363
Authors:
FOX PJ
Citation: Pj. Fox, SERVICE USE AND COST OUTCOMES FOR PERSONS WITH ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 125-134
Authors:
ERNST RL
HAY JW
Citation: Rl. Ernst et Jw. Hay, ECONOMIC RESEARCH ON ALZHEIMER-DISEASE - A REVIEW OF THE LITERATURE, Alzheimer disease and associated disorders, 11, 1997, pp. 135-145
Authors:
TERESI JA
HOLMES D
Citation: Ja. Teresi et D. Holmes, METHODOLOGICAL ISSUES IN COGNITIVE ASSESSMENT AND THEIR IMPACT ON OUTCOME MEASUREMENT, Alzheimer disease and associated disorders, 11, 1997, pp. 146-155
Authors:
HAZUDA HP
Citation: Hp. Hazuda, MINORITY ISSUES IN ALZHEIMER-DISEASE OUTCOMES RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 156-161
Authors:
PHILLIPS CD
MORRIS JN
Citation: Cd. Phillips et Jn. Morris, THE POTENTIAL FOR USING ADMINISTRATIVE AND CLINICAL-DATA TO ANALYZE OUTCOMES FOR THE COGNITIVELY IMPAIRED - AN ASSESSMENT OF THE MINIMUM DATA SET FOR NURSING-HOMES, Alzheimer disease and associated disorders, 11, 1997, pp. 162-167
Authors:
MAGAZINER J
Citation: J. Magaziner, USE OF PROXIES TO MEASURE HEALTH AND FUNCTIONAL OUTCOMES IN EFFECTIVENESS RESEARCH IN PERSONS WITH ALZHEIMER-DISEASE AND RELATED DISORDERS, Alzheimer disease and associated disorders, 11, 1997, pp. 168-174
Authors:
HOLMES D
HURLEY A
LAWTON MP
Citation: D. Holmes et al., OUTCOME MEASURES FOR ALZHEIMER-DISEASE RESEARCH - THE CONTINUUM OF DOMAINS TO BE MEASURED, Alzheimer disease and associated disorders, 11, 1997, pp. 175-178
Authors:
BURGIO L
LEON J
Citation: L. Burgio et J. Leon, USING PATIENT AND PROXY REPORTS AS OUTCOME MEASURES IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 179-180
Authors:
BERG L
MONTGOMERY R
Citation: L. Berg et R. Montgomery, METRICS OF EFFECTIVENESS WITHIN ALZHEIMER-DISEASE RESEARCH AND ACROSSDISEASES, Alzheimer disease and associated disorders, 11, 1997, pp. 181-183
Authors:
FORTINSKY RH
HAZUDA HP
LARSON EB
LINDEMAN DA
MULLICAN CA
TETZLOFF I
WETLE T
Citation: Rh. Fortinsky et al., PRINCIPLES UNDERLYING SELECTION OF OUTCOMES IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 184-185
Authors:
MASLOW K
WHITEHOUSE P
Citation: K. Maslow et P. Whitehouse, DEFINING AND MEASURING OUTCOMES IN ALZHEIMER-DISEASE RESEARCH - CONFERENCE FINDINGS, Alzheimer disease and associated disorders, 11, 1997, pp. 186-195
Citation: DEFINING AND MEASURING OUTCOMES FOR ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 196-198
Authors:
GREEN RC
CLARKE VC
THOMPSON NJ
WOODARD JL
LETZ R
Citation: Rc. Green et al., EARLY DETECTION OF ALZHEIMER-DISEASE - METHODS, MARKERS, AND MISGIVINGS, Alzheimer disease and associated disorders, 11, 1997, pp. 1-5
Authors:
WHITEHOUSE PJ
Citation: Pj. Whitehouse, SLOWING THE PROGRESSION OF ALZHEIMERS-DISEASE - METHODOLOGY AND ETHICAL ISSUES - ROUND-TABLE HELD AT THE 5TH INTERNATIONAL-CONFERENCE ON ALZHEIMERS-DISEASE AND RELATED DISORDERS, JULY 24-29, 1996, OSAKA, JAPAN- INTRODUCTION, Alzheimer disease and associated disorders, 11, 1997, pp. 5-5
Authors:
ROSSOR MN
FOX NC
FREEBOROUGH PA
ROQUES PK
Citation: Mn. Rossor et al., SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - MONITORING PROGRESSION, Alzheimer disease and associated disorders, 11, 1997, pp. 6-9
Authors:
MCGEER P
ROSSOR MN
BODICK NC
Citation: P. Mcgeer et al., SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - MONITORING PROGRESSION- DISCUSSION, Alzheimer disease and associated disorders, 11, 1997, pp. 9-9
Authors:
LEBER P
Citation: P. Leber, SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - METHODOLOGIC ISSUES, Alzheimer disease and associated disorders, 11, 1997, pp. 10-20
Authors:
GRACON S
LEBER P
LUCCA U
KNOPMAN D
Citation: S. Gracon et al., SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - METHODOLOGIC ISSUES - DISCUSSION, Alzheimer disease and associated disorders, 11, 1997, pp. 20-21
Authors:
WHITEHOUSE PJ
Citation: Pj. Whitehouse, PHARMACOECONOMICS OF DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 22-32
Authors:
BODICK NC
WHITEHOUSE PJ
LEVKOFF S
Citation: Nc. Bodick et al., PHARMACOECONOMICS OF DEMENTIA - DISCUSSION, Alzheimer disease and associated disorders, 11, 1997, pp. 32-33
Authors:
POST SG
Citation: Sg. Post, SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - ETHICAL ISSUES, Alzheimer disease and associated disorders, 11, 1997, pp. 34-36
Authors:
LEBER P
POST SG
GREEN RC
WHITEHOUSE PJ
RABINS PV
LIEBLER ET
ROGERS J
MALFLIET TOT
Citation: P. Leber et al., SLOWING THE PROGRESSION OF ALZHEIMER-DISEASE - ETHICAL ISSUES - GENERAL DISCUSSION, Alzheimer disease and associated disorders, 11, 1997, pp. 37-39
Authors:
HAY JW
SANO M
WHITEHOUSE PJ
Citation: Jw. Hay et al., THE COSTS AND SOCIAL BURDENS OF ALZHEIMER-DISEASE - WHAT CAN AND SHOULD BE DONE, Alzheimer disease and associated disorders, 11(4), 1997, pp. 181-183
Authors:
CAVALLO MC
FATTORE G
Citation: Mc. Cavallo et G. Fattore, THE ECONOMIC AND SOCIAL BURDEN OF ALZHEIMER-DISEASE ON FAMILIES IN THE LOMBARDY REGION OF ITALY, Alzheimer disease and associated disorders, 11(4), 1997, pp. 184-190
Authors:
WIMO A
KARLSSON G
NORDBERG A
WINBLAD B
Citation: A. Wimo et al., TREATMENT OF ALZHEIMER-DISEASE WITH TACRINE - A COST-ANALYSIS MODEL, Alzheimer disease and associated disorders, 11(4), 1997, pp. 191-200